REGN

REGN options carry 34.6K contracts of open interest across 17 expiries, 6.8% of it in the Oct 16 contract, with 0.83 puts per call.

91% of open interest sits beyond the Oct 16 contract · 116 strikes listed for it · 34.6K contracts open in all

The Oct 16 contract holds 1.55K calls and 805 puts, the most call OI at $890.00 and the most put OI at $810.00; max pain $790.00, +4.2% from the close.

Call OI, contracts

1.55K1,551 contracts

Put OI, contracts

805805 contracts

Puts per call, by OI

0.52all expiries 0.83

Max pain

$790.00+4.2% from the close

Strikes listed

116for this expiry

Revenue $4.29B, +17% on a year earlier; profit $1.30B, −6.8% in the Jun 2026 quarter, consolidated.

REGN trades at 19 times trailing earnings against 20 for its industry, 2.3 times book value, revenue +9.3% over twelve months, a 0.25% dividend yield, market cap $71.24B.

Market cap

$71.24Bon Sep 30

Price to earnings

19consolidated · four quarters to Jun 2026 · industry 20

Trailing EPS

$40.38diluted · consolidated · four quarters to Jun 2026

Price to book

2.3consolidated · balance sheet to Jun 2026

Book value a share

$337.52consolidated · balance sheet to Jun 2026

Debt to equity

—

Return on equity

14%trailing profit over average equity · consolidated

Dividend yield

0.25%$1.88 a share in 365 days

Price to sales

4.6market cap over revenue, four quarters to Jun 2026

Shares outstanding

94Mon Sep 30

Revenue, trailing 12 months

$15.53Bfour quarters to Jun 2026

Revenue growth, 12 months

▲ +9.3%against the twelve months before

Revenue 3-year CAGR

▲ +7.0%trailing twelve months against the twelve months 3 years earlier · consolidated

Profit, trailing 12 months

$4.33Bfour quarters to Jun 2026

Profit growth, 12 months

▼ −2.9%against the twelve months before

Profit 3-year CAGR

▲ +0.23%trailing twelve months against the twelve months 3 years earlier · consolidated

13F managers hold 190% of shares, BlackRock, Inc. the largest at 19%, VANGUARD CAPITAL MANAGEMENT LLC 14% and Dodge & Cox 10%, as filed for the quarter to Jun 2026.

• BlackRock, Inc. 19.4%
• VANGUARD CAPITAL MANAGEMENT LLC 14.1%
• Dodge & Cox 10.4%
• Other 13F managers 143.3%

Held by 13F managers

190%of shares outstanding

Shares held

176M+3.8% on Mar 2026 among managers filing both

Managers holding

1,2501,309 a quarter earlier

Largest holder

19%BlackRock, Inc.

No open-market insider buying or selling in the last 90 days.

Nothing upcoming on record; the last was a dividend of $0.94 a share, ex-date Aug 18, 2026.

REGN is −8.0% over 20 sessions against the S&P 500's +0.1%, 12% below its 52-week high, realised volatility 29% annualised.

Average true range, 14

$202.6% of the close

Average day's range, 20

$182.4% of the close

Volume against 20 sessions

1.20×872K vs 735K average

Realised volatility, 20

29%≈ ±1.8% a session · moved more than that on 6 of 20

Realised volatility, 60

30%≈ ±1.9% a session · moved more than that on 15 of 60

Beta to S&P 500, 60

0.90moved with S&P 500 on 38 of 60 sessions

Last 20 sessions

7 up · 13 downof 20

Last 60 sessions

32 up · 28 downof 60

Best session, 250

▲ +6.2%Jul 30

Worst session, 250

▼ −9.8%May 18

Short sales were 44% of reported volume on Sep 30, 2026, against 54% over the last 25 sessions.

Company

Regeneron Pharmaceuticals Inc

Exchange

XNAS

Industry

Pharmaceutical Preparations · SEC standard industrial classification

SEC CIK

872589

Sessions on record

131

Price source

End of day · delayed

Computed

1 Oct, 10:38 pm IST

OI Charts is not a registered investment adviser or broker-dealer. Prices, filings and open interest are public data and arithmetic on it, not a basis for any investment decision.